Nafld fibrosis score chart. 1 One is nonalcoholic fatty liver (NAFL), which is defined as...

Nafld fibrosis score chart. 1 One is nonalcoholic fatty liver (NAFL), which is defined as 5% or greater hepatic steatosis without evidence of hepatocellular injury or fibrosis. 1,2 Although liver fibrosis is the strongest histologic predictor of liver-related outcome and all-cause mortality in Aug 5, 2025 · The FIB-4 score serves as a screening tool to identify individuals who might have significant liver fibrosis. Whilst it is clear that NAFLD is common within the general population, this generally causes little in the way of morbidity or mortality. The BARD Score for NAFLD Fibrosis predicts the risk of advanced fibrosis for NAFLD patients. The management is with lifestyle measures, but it is important to identify those who are at risk of We would like to show you a description here but the site won’t allow us. NAFLD Fibrosis Score Calculator Estimate the risk of liver fibrosis based on clinical and laboratory data The FIB-4 index is the preferred noninvasive initial test to assess the risk of NAFLD with liver fibrosis. The NAFLD Fibrosis Score is recommended by the American Association for the Study of Liver Diseases (AASLD), the American College of Gastroenterology (ACG), and the American buscar Menu NAFLD fibrosis score Higado graso no alcohólico / determinación del grado de fibrosis DM/IFG* Calcular Borrar A Fibrosis Score estimates how much scarring (fibrosis) is present in your liver without a biopsy. Fibrosis scoring systems (FIB-4 and ELF) This page includes information about the ELF and Fib-4 fibrosis scoring systems. This FIB-4 calculator is a simple tool for assessing the probability of NAFLD liver fibrosis. Jun 13, 2020 · Histological Scoring System for Nonalcoholic Fatty Liver Disease Components of NAFLD Activity Score (NAS) and Fibrosis Staging Nonalcoholic Steatohepatitis Clinical Research Network Please mail comments, corrections or suggestions to the TPIS administration at the UPMC. The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. Non-alcoholic fatty liver disease (NAFLD) is now the commonest cause of abnormal liver function tests (LFTs) in the UK with approximately a third of the population being affected. Jun 16, 2025 · However, ALT and AST levels do not tell you how much scarring (fibrosis) may be present in your liver or predict how much liver damage will develop. NAFLD Fibrosis Score (NFS) — an intermediate or high score (greater than minus 1. The NAFLD-LFS is a non-invasive screening method for liver fat in non-alcoholic fatty liver disease based on insulin, ALT and AST values and diagnosis of metabolic syndrome and type 2 diabetes. The given below is the NAFLD fibrosis score calculator to calculate the non-alcoholic fatty liver disease activity score with ease. The NAFLD Fibrosis Score is a validated, noninvasive tool for identifying patients whose MASLD has advanced to liver fibrosis. The NAFLD fibrosis score can assist healthcare professionals inentifying the severity of liver fibrosis in NAFLD patients without the need for a liver biopsy, offering a non-invasive and practical approach to assess liver health. These results should not be used as a substitute for professional medical judgment, diagnosis, or treatment. 3-2. The Fibrosis-4 (FIB-4) Index for Liver Fibrosis is a non-invasive scoring system based on several laboratory tests that help to estimate the amount of scarring in the liver. The NAFLD Fibrosis Score Calculator is an instrumental tool for gauging the risk of fibrosis in individuals with NAFLD. The information presented The NAFLD fibrosis score: a noninvasive system that identifies liver fibrosis in patients with NAFLD. The NAFLD fibrosis score is a validated non-invasive tool derived from large cohorts to stratify fibrosis in non-alcoholic fatty liver disease. On the template, a view will give you all the patient's relevant medical history and blood results, which makes calculating the score via the link quick and easy to do. Find out more about fibrosis. Nonalcoholic fatty liver disease. The NAFLD fibrosis score has the benefit of a good negative predictive value for excluding ADVICE Enhanced Liver Fibrosis (ELF) Score should be considered for the assessment of advanced liver fibrosis in patients with NAFLD. Always consult with a qualified healthcare provider regarding any medical concerns, decisions, or interpretation of results. NAFLD is often asymptomatic, but may occasionally cause non-specific symptoms of fatigue, general malaise, and abdominal discomfort. The template also includes guidance for how to interpret the score too. Feb 3, 2025 · FIB-4 Score >2. To complete the Non-Alcoholic Fatty Liver Disease (NAFLD) Fibrosis Score Calculator and score your patient: Any relevant data from the patient record automatically populates. FIB-4 score is a powerful instrument for ruling out or confirming a diagnosis of advanced fibrosis. Find out about scoring systems for cirrhosis. Fibrosis means scarring of the liver. It is closely linked with obesity as well as type 2 diabetes. One hundred seven . 6 were indeterminate, requiring further testing. It is particularly useful in common liver conditions such as non-alcoholic fatty liver disease (NAFLD), non-alcoholic steatohepatitis (NASH), and chronic viral hepatitis (Hepatitis C and B), which can lead to liver damage and cirrhosis. It is a spectrum of The NAFLD fibrosis score is a validated non-invasive tool derived from large cohorts to stratify fibrosis in non-alcoholic fatty liver disease. But if the damage continues it can cause cirrhosis. g. We Non Alcoholic Fatty Liver Disease Pathway (For patients aged 30 yrs – 75 yrs) +ive liver screen Refer Hepatology AIM: To study whether the severity of liver fibrosis estimated by the nonalcoholic fatty liver disease (NAFLD) fibrosis score can predict all-cause mortality, cardiac complications, and/or liver complications of patients with NAFLD over long-term The FIB-4 score and NAFLD fibrosis score are recom-mended for identifying patients at risk of fibrosis. It combines routine blood tests (and sometimes age/height/weight) in a validated formula to classify your risk of advanced fibrosis (significant scarring that can progress to cirrhosis). In some people with NAFLD these liver enzymes may be normal as well Fibrosis assessment tests These blood tests result in a score that estimates your level of liver scarring or fibrosis. Test Summary Enhanced Liver Fibrosis (ELF) Score Test code: 10350 Clinical use Assess likelihood that nonalcoholic steatohepatitis (NASH) will progress to cirrhosis and liver-related clinical events (eg, hepatic decompensation event, Model for End-Stage Liver Disease score ≥15, liver transplantation, or death) We would like to show you a description here but the site won’t allow us. Nov 28, 2025 · The NAFLD Fibrosis Score is generated by inputting six distinct variables into a mathematical formula. Find out how the score compares with a FibroScan and other diagnostic tests for NAFLD. (Repeat testing every 2 years is suggested for patients with a low FIB-4 index. The ranges of fibrosis results in the table are estimates. They include: Sep 6, 2023 · Reliability of Test Scores This table shows liver diseases, ranges of fibrosis results, and the matching fibrosis score. ELF Score ≥10. Der kürzlich publizierte NAFLD-Fibrose Score erlaubt eine nicht invasive Abgrenzung von Patienten mit ausgeprägter Fibrose von Patienten ohne ausgeprägte Fibrose. Evaluate age, BMI, diabetes, AST/ALT ratio, albumin, and platelet count for accurate fibrosis prediction. Twenty percent of patients with NAFLD progress to nonalcoholic steatohepatitis (NASH), which is strongly linked to liver fibrosis and can lead to cirrhosis, liver transplantation, or death. Note: NAFLD is now termed metabolic dysfunction-associated steatotic liver disease (MASLD), and nonalcoholic steatohepatitis (NASH) is called metabolic dysfunction-associated steatohepatitis (MASH). City and Hackney Non-Alcoholic Fatty Liver Disease (NAFLD) pathway NAFLD comprises a spectrum of: fatty liver non-alcoholic steatohepatitis fibrosis cirrhosis. This tool does not provide medical advice, diagnosis, or treatment. Calculate NAFLD (Non-Alcoholic Fatty Liver Disease) Fibrosis Score to assess liver fibrosis risk. Free online tool for medical professionals. Sep 20, 2021 · NAFLD/NASH screening steps Step 1: Identifying patients with clinically significant hepatic fibrosis (fibrosis stage 2 or higher) is important for targeted efforts at preventing disease progression. Hepatology 2007; 45: 846-854 3) Nakano M et al. It leverages metabolic risk factors and simple laboratory markers to triage patients who need elastography or biopsy. 1 It’s a condition characterized by the presence of hepatic steatosis, typically associated with type 2 diabetes mellitus and obesity. A simple blood test can help identify those at risk. Your local guidance may differ. Step 2 Introduction: The SAFE (Steatosis-associated Fibrosis Estimator) score is a scoring system to categorize NAFLD patients by their risk of having significant liver fibrosis (stage 2 or higher) and long-term outcome. There is a need for accurate biomarkers of fibrosis for population screening of alcohol-related and non-alcoholic fatty liver disease (ALD, NAFLD). It affects 20-30% of population (and the prevalence is increasing), and of these 5-6% can progress to NASH, fibrosis or cirrhosis. Hierdurch läßt sich nach Meinung der Autoren der Studie die Mehrzahl der Leberbiopsien zur Feststellung bzw As per the locally agreed primary care pathway, the ELF test should be considered for the assessment of liver fibrosis in adult patients with NAFLD. from publication: Exploring Varied Treatment Strategies for Metabolic Dysfunction Given the high prevalence of MAFLD, there is an unmet need for a score to noninvasively triage patients who need TE and possible biopsy. Learn when it's used, how the score is calculated, and how to interpret results. Non-alcoholic steatohepatitis (NASH) defines a subgroup of NAFLD where there is a risk of progression to advanced liver fibrosis, cirrhosis, or rarely, hepatocellular cancer. Your results can range from normal to advanced. The NAFLD fibrosis score calculator identifies liver fibrosis in patients with non-alcoholic fatty liver disease (NAFLD). [Validity of the NAFLD fibrosis score in a Japanese population]. 3 were classified as not having advanced fibrosis, while patients with a FIB-4 score >2. It is a stage of long-term liver disease. Jul 10, 2025 · What is the NAFLD Fibrosis Score? The NAFLD Fibrosis Score (NFS) is a widely used and validated clinical scoring system designed to identify patients with non-alcoholic fatty liver disease (NAFLD) who are at high risk for advanced liver fibrosis (stages F3-F4). 2007 Apr;45 (4):846-54. A liver with fibrosis can still do all its usual jobs. The nonalcoholic fatty liver disease fibrosis score (NFS) is comprised of unique metabolic risk indicators that may accurately predict residual cardiovascular (CV) risk in patients with established coronary disease and metabolic dysfunction. 51 suggests advanced liver fibrosis and is an indication for referral to a specialist in hepatology. A noninvasive way to assess risk of NASH disease progression Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, affecting at least a quarter of the global adult population. 455 are used to rule out severe liver fibrosis (these patients would be safe to monitor in primary care). The NAFLD (Non-Alcoholic Fatty Liver Disease) Fibrosis Score estimates amount of scarring in the liver based on several laboratory tests. Please note: The use of the FIB-4 score is not validated where a patient is over 75 years of age. These groups include patients with type 2 diabetes, patients with two or more metabolic risk factors, and those with incidental findings of hepatic steatosis or elevated amino transferases. There are several liver conditions that are defined under this term which includes steatosis which is or not accompanied by various degrees of inflammation and cannot be appointed to alcohol co Aug 23, 2022 · Learn how doctors use a panel of blood tests to calculate your NAFLD fibrosis score and predict your risk of liver scarring. The exact prevalence is not known, but population studies from the USA and China using magnetic resonance spectroscopy estimate that approximately 30% of the general population have steatosis. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases. It relies on readily available clinical information and routinely measured laboratory data. The NAFLD fibrosis score has the benefit of a good negative predictive value for excluding We would like to show you a description here but the site won’t allow us. NAFLD Fibrose Score Bei Patienten mit nicht-alkoholischer Fettlebererkrankung (NAFLD) endet die Erkrankung häufig in einer Leberzirrhose. The Nonalcoholic fatty liver disease (NAFLD) Activity Score (NAS) has been applied as a method for evaluating treatment response, and a ≥2-point improvement in NAS has been commonly used as an accepted end point in phase 2b clinical trials in nonalcoholic steatohepatitis. To use the table, find the liver disease that you have on the left side of the table. Jun 15, 2017 · The FIB-4 score and NAFLD fibrosis score are recommended for identifying patients at risk of fibrosis. This is a health tool that assesses the level of fibrosis, scarring of the liver, consistent with the existence of nonalcoholic fatty liver disease (NAFLD). 455), suggests advanced liver fibrosis. Age is a factor, as the prevalence of NAFLD and its progression to fibrosis tend to increase with advancing years. Select the status of impaired fasting glucose/diabetes and enter the details of age, BMI, AST/ALT ratio, platelets count, and albumin level, the NAFLD calculator will update you the non alcoholic fatty liver score and correlated fibrosis severity within the FIB-4 Calculator for NAFLD NB: This is only valid for non-alcoholic fatty liver disease (NAFLD) and is intended for use in conjunction with the NCL Abnormal LFT pathway. Bei Patienten mit nicht-alkoholischer Fettlebererkrankung (NAFLD) endet die Erkrankung häufig in einer Leberzirrhose. Der NAFLD-Fibrose Score erlaubt eine nicht invasive Abgrenzung von Patienten mit ausgeprägter Fibrose von Patienten ohne ausgeprägte Fibrose. , 2017). If the person is at high risk of advanced liver fibrosis, refer to a hepatology specialist for further assessment and management. Ann Epidemiol 2007; 17: 863-869 2) Angulo P et al. Hepatology. PMID: 17393509. [7] These patients should be further assessed for a diagnosis and referred to GI if indicated. It combines six readily available clinical and laboratory variables: age, BMI, presence of diabetes, AST, ALT, platelet count, and Mar 28, 2025 · The nonalcoholic fatty liver disease (NAFLD) fibrosis score is a less invasive alternative to a liver biopsy that can help predict your risk for liver damage. Jul 27, 2025 · The NAFLD Fibrosis Score is calculated using six distinct variables, each offering insights into liver health and potential fibrosis progression. Aug 23, 2022 · Doctors use the NAFLD fibrosis score to predict how much scarring there is in the liver. The aims of this study were to identify additional factors and then to build an enhanced version of the BARD score. This NAFLD fibrosis score calculator determines the degree of hepatic fibrosis in patients with non-alcoholic fatty liver disease. We would like to show you a description here but the site won’t allow us. Sterling R, Lissen E, Clumeck N, Sola R, Correa M, Montaner J et al. The information presented Fibrosis-4 (FIB-4) Index for Liver Fibrosis – Noninvasive estimate of liver scarring to assess the need for biopsy (see MDcalc FIB-4 Score) Nonalcoholic fatty liver disease (NAFLD) is now the leading cause of chronic liver disease in the world. Die Mehrzahl der Leberbiopsien zur Feststellung oder zum Ausschluss einer Leberfibrose kann damit vermieden a simple scoring system accurately separates patients with NAFLD with and without advanced fibrosis, rendering liver biopsy for identification of advanced fibrosis unnecessary in a substantial proportion of patients. Your actual fibrosis score may not match the fibrosis score in the table. , transient We would like to show you a description here but the site won’t allow us. NAFLD Fibrosis Score NAFLD Fibrosis Score is a non-invasive tool used to assess the severity of fibrosis in patients with non-alcoholic fatty liver disease. AASLD Practice Guideline on imaging-based noninvasive liver disease assessments of hepatic fibrosis and steatosis Corresponding article: Imaging-based non-invasive liver disease assessment for staging liver fibrosis in chronic liver disease: A systematic review supporting the AASLD Practice Guideline This score consists of 3 lab values that are widely available outside of specialized hepatology clinics. Fibrosis (FIB)-4 Score (FIB-4) — a score of greater than 2. Scores below -1. NAFLD can range from mild to severe. Effective risk stratification in primary care with non-invasive fibrosis scores, such as fibrosis 4 (FIB-4) index and NAFLD fibrosis score (NFS), optimizes healthcare resource utilization Mar 4, 2026 · Literatur: 1) Adams LA, Lindor KD. We constructed and validated a scoring system consisting of routinely measured and readily available clinical and laboratory data to separate NAFLD patients with and without advanced fibrosis. Nonalcoholic fatty liver disease (NAFLD) affects one-fourth of the global population and is the most common cause of chronic liver disease. Nov 15, 2020 · There are two manifestations of NAFLD (Figure 1). These variables combine patient-specific data with results from standard laboratory blood work, which are recognized factors in the progression of liver disease. Non-alcoholic fatty liver disease (NAFLD) is common in primary care. Mayo Clinic The Alcoholic Liver Disease/Nonalcoholic Fatty Liver Disease Index (ANI) calculator is a novel scoring system to distinguish alcoholic liver disease (ALD) from nonalcoholic fatty liver disease (NAFLD), for use by medical professionals. The Liver Fibrosis template includes the BARD Score, Fibrosis 4 Score and NAFLD Fibrosis Score. 67 in patients with NAFLD has 80% positive predictive value for detecting advanced fibrosis. 67 were classified as having advanced fibrosis. This table describes the scoring and staging requirements for the NAFLD activity score and fibrosis score. This fibrosis 4 (FIB4) score calculator evaluates liver fibrosis based on age, platelet count, AST and ALT to help with cirrhosis diagnosis. Liver fibrosis stage 2 or higher (≥F2) increases future risk of morbidity and mortality. ) Patients in the high-risk groups with an indeterminate or high FIB-4 index should be considered for further testing with the ELF score. The score should not be used as a surrogate for NASH diagnosis (see Brunt and Kleiner 2011 for details). NAFLD Spectrum of pathology starting with hepatic steatosis through inflammation (steatohepatitis) to fibrosis ‘Hepatic manifestation’ of the metabolic syndrome Accumulation of fat in the liver Prevalence 20-30% Jan 12, 2025 · The Fatty Liver Fibrosis Score Calculator provides general health information for educational purposes only. Patients with nonalcoholic fatty liver disease (NAFLD) and advanced liver fibrosis are at the highest risk for progressing to end-stage liver disease. NAFLD-FS is calculated using age, AST, ALT, platelet level, albumin level, presence of hyperglycemia, and Body Mass Index (BMI): all factors inversely related to severity of liver fibrosis in NASH (Chalasani et al. [4] Those with FIB-4 scores 1. We compared the performance of the enhanced liver fibrosis (ELF) test to the fibrosis-4 index (FIB-4) and NAFLD fibrosis score (NFS), using transient elastography as the reference standard. NAFLD affects 25% of the population, making it the most common liver disease worldwide. 2007;45 (4):846-854. An ELF Score ≥10. 51, then advanced liver fibrosis is unlikely. Normal: This means your liver has no scarring, or mild scarring. Problems arise with the development of inflammation and fibrosis. 1,2 Although liver fibrosis is the strongest histologic predictor of liver-related outcome and all-cause mortality in The Nonalcoholic fatty liver disease (NAFLD) Activity Score (NAS) has been applied as a method for evaluating treatment response, and a ≥2-point improvement in NAS has been commonly used as an accepted end point in phase 2b clinical trials in nonalcoholic steatohepatitis. Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. It is important to be able to assess the severity of the disease process; in particular, it is essential to be able to assess the amount of fibrosis present, as this is the best predictor of A sample report can be seen below: In clinical trials for NAFLD/NASH diagnosis, patients with a FIB-4 score <1. This NAFLD fibrosis score calculator stratifies the degree of fibrosis to the liver in nonalcoholic fatty liver disease patients by assigning a specific stage. Practitioners only have the available options of the FIB-4 index, initially developed to predict fibrosis in hepatitis patients, and the NAFLD score, developed to predict fibrosis in NAFLD patients. We developed and validated a score to aid in the initial assessment of liver fibrosis for Disclaimer The calculations and data provided on this website are for informational purposes only and do not constitute medical advice. Clinicians use it to rule out low risk, flag high risk, and decide who needs imaging (e. 51 suggests advanced liver fibrosis and is an indication for referral to Hepatology clinic. Calculate NAFLD Fibrosis Score to assess liver fibrosis risk in non-alcoholic fatty liver disease. Use it to screen for fibrotic nonalcoholic steatohepatitis (NASH) in high-risk patients. The NAFLD fibrosis score is used to distinguish between patients with nonalcoholic fatty liver disease who have (F3-F4) and do not have (F0-F2) advanced fibrosis. By providing critical insights into your health, this calculator sets the stage for informed decision-making and proactive health management. If the ELF Score is <10. When determining your actual fibrosis score, in addition to your fibrosis measurement, your provider will take into consideration your health history and the grade of steatosis. If you have more than one liver disease you may not be able to use this table. Chalasani N, Younossi Z, Lavine JE, et al. Use our NAFLD Fibrosis Score Calculator to assess liver fibrosis risk, improve monitoring, and support better overall liver health. 2 If left undiagnosed, many patients with NAFLD progress Disclaimer The calculations and data provided on this website are for informational purposes only and do not constitute medical advice. Using your liver stiffness result to find your fibrosis score Your healthcare provider will use your liver stiffness result and medical history to find out your fibrosis score. Nihon Shokakibyo Gakkai Zasshi 2012; 109: 751-759 4 Diagnosis and the follow-up of liver fibrosis, steatosis, and inflammation Estimating hepatic fibrosis Assessing inflammation for metabolic diseases Assessing severity of nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease with steatosis (NAFLD) Assessing steatosis or fatty liver Reassuring patients with steatosis only, without fibrosis Managing patients with Jul 3, 2013 · The BARD score is a model to detect advanced liver fibrosis in nonalcoholic fatty liver disease (NAFLD) patients. 67 suggests advanced liver fibrosis. Patient characteristics required are age and Body Mass Index (BMI). drlrlx lozu mfvzjhg ijsrt uhnb tcjko afhhk pwvphwv drrdk bgjx